# Pemetrexed Followed by Docetaxel or in Reverse Sequence

> **NCT01442909** · PHASE4 · COMPLETED · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 44 (actual)

## Conditions studied

- Non-small-cell Lung Cancer

## Interventions

- **DRUG:** Docetaxel and pemetrexed

## Key facts

- **NCT ID:** NCT01442909
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2011-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01442909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01442909, "Pemetrexed Followed by Docetaxel or in Reverse Sequence". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01442909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*